The kallikrein-kinin system (KKS) has been previously linked to glucose homeostasis. In isolated muscle or fat cells, acute bradykinin (BK) stimulation was shown to improve insulin action and increase glucose uptake by promoting glucose transporter 4 translocation to plasma membrane. However, the role for BK in the pathophysiology of obesity and type 2 diabetes remains largely unknown. To address this, we generated genetically obese mice (ob/ob) lacking the BK B2 receptor (obB2KO). Despite similar body weight or fat accumulation, obB2KO mice showed increased fasting glycemia (162.3±28.2 mg/dl vs 85.3±13.3 mg/dl), hyperinsulinemia (7.71±1.75 ng/ml vs 4.09±0.51 ng/ml) and impaired glucose tolerance when compared with ob/ob control mice (obWT), indicating insulin resistance and impaired glucose homeostasis. This was corroborated by increased glucose production in response to a pyruvate challenge. Increased gluconeogenesis was accompanied by increased hepatic mRNA expression of forkhead box protein O1 (FoxO1, four-fold), peroxisome proliferator-activated receptor gamma co-activator 1-alpha (seven-fold), phosphoenolpyruvate carboxykinase (PEPCK, three-fold) and glucose-6-phosphatase (eight-fold). FoxO1 nuclear exclusion was also impaired, as the obB2KO mice showed increased levels of this transcription factor in the nucleus fraction of liver homogenates during random feeding. Intraportal injection of BK in lean mice was able to decrease the hepatic mRNA expression of FoxO1 and PEPCK. In conclusion, BK modulates glucose homeostasis by affecting hepatic glucose production in obWT. These results point to a protective role of the KKS in the pathophysiology of type 2 diabetes mellitus. KEYWORDS: bradykinin; gluconeogenesis; kinin receptor; leptin; ob/ob; obesity The pathophysiology of type 2 diabetes mellitus (T2DM) involves innumerous metabolic and endocrine alterations, including changes in the carbohydrate, lipid and protein metabolisms. T2DM is directly linked with insulin resistance and the inability of pancreatic beta cells to compensate for these changes. 1 There is also a strong association between T2DM and obesity 1,2 that persists independently of gender or ethnic group. In this interaction, the weight gain of obese subjects seems to precede the development of T2DM. 3 Kinins are vasoactive peptides produced in the circulatory system and other tissues by the action of serine proteases called kallikreins. The kallikrein-kinin system (KKS) modulates pain, vasodilatation, vascular permeability, inflammation and edema and has been linked to insulin resistance. [4] [5] [6] [7] Bradykinin (BK), the agonist of the constitutively expressed BK B2 receptor (BKB2R), has been reported to increase glucose uptake in skeletal muscle and adipose tissue. 8 At the same time, the kinin B1 receptor and its agonist, the des-arg 9 -kinin, have been shown to control leptin sensitivity 7 and insulin secretion. 9 Despite evidence that acute BK stimulation improves glucose uptake, the role for BK and BKB2R in the pathophysiology of T2DM is still not clear. In isolated systems, it has been shown that BK can trigger the translocation of the glucose transporter 4 (GLUT4) in adipose tissue and muscle either directly 8 or by increasing insulin sensitivity. [10] [11] [12] Miyata et al 11 showed that BK can promote insulin action, augmenting both the phosphorylation of the insulin receptor
The pathophysiology of type 2 diabetes mellitus (T2DM) involves innumerous metabolic and endocrine alterations, including changes in the carbohydrate, lipid and protein metabolisms. T2DM is directly linked with insulin resistance and the inability of pancreatic beta cells to compensate for these changes. 1 There is also a strong association between T2DM and obesity 1,2 that persists independently of gender or ethnic group. In this interaction, the weight gain of obese subjects seems to precede the development of T2DM. 3 Kinins are vasoactive peptides produced in the circulatory system and other tissues by the action of serine proteases called kallikreins. The kallikrein-kinin system (KKS) modulates pain, vasodilatation, vascular permeability, inflammation and edema and has been linked to insulin resistance. [4] [5] [6] [7] Bradykinin (BK), the agonist of the constitutively expressed BK B2 receptor (BKB2R), has been reported to increase glucose uptake in skeletal muscle and adipose tissue. 8 At the same time, the kinin B1 receptor and its agonist, the des-arg 9 -kinin, have been shown to control leptin sensitivity 7 and insulin secretion. 9 Despite evidence that acute BK stimulation improves glucose uptake, the role for BK and BKB2R in the pathophysiology of T2DM is still not clear. In isolated systems, it has been shown that BK can trigger the translocation of the glucose transporter 4 (GLUT4) in adipose tissue and muscle either directly 8 or by increasing insulin sensitivity. [10] [11] [12] Miyata et al 11 showed that BK can promote insulin action, augmenting both the phosphorylation of the insulin receptor and the insulin receptor substrate-1 in skeletal muscle and rat L6 myoblasts. Kishi et al 8 concluded that BK increases GLUT4 translocation in three different cell lines (L6 myotubes, 3T3-L1 adipocytes and CHO) independently on insulin. The effect of BK on glucose uptake is nitric oxide dependent, and thus absent in adipocytes of endothelial NO synthase knockout mice. 13 Furthermore, BK modulates the feedback inhibition of insulin signaling at the level of insulin receptor substrate-1. 12 BK and nitric oxide are also involved in the effects of leptin on glucose uptake. 14 Patients treated with angiotensin-converting enzyme inhibitors are less susceptible to develop T2DM. 15 Angiotensin-converting enzyme has an important role not only by converting angiotensin I to angiotensin II and thereby increasing blood pressure, but also by inactivating kinin peptides. This leads to an increase of kinin levels in patients treated with angiotensin-converting enzyme inhibitors, [16] [17] [18] which has been proposed to protect these patients against T2DM through a mechanism that has not been completely elucidated. 19 To study the involvement of BK in the pathophysiology of T2DM in the context of obesity, the main etiological cause of T2DM in humans, we studied obese ob/ob mice lacking BKB2R (obB2KO). We were thus able to explore how the deficiency of BKB2R influences glucose homeostasis of obese mice (obWT). As liver is an important organ in the context of T2DM, we were interested in the hepatic metabolism of these animals. 20 Despite remaining as obese as their ob/ob controls, the obB2KO animals showed increased gluconeogenesis and increased mRNA expression and nuclear accumulation of the transcription factor forkhead box protein O1 (FoxO1). This factor is known to control expression of the enzymes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) in the liver, both regulatory enzymes of gluconeogenesis. 21 Consistent with changes in FoxO1, both PEPCK and G6Pase were increased in liver of obB2KO mice. Conversely, intraportal injection of BK in lean mice acutely decreased FoxO1 and PEPCK mRNA expression in the liver. In this work we show, for the first time, that KKS is strongly involved in glucose metabolism, not only acting in peripheral glucose uptake as previously described but also by affecting hepatic glucose production.
MATERIALS AND METHODS Animals
Lep ob /Lep ob (ob/ob) and Bdkrb2 tm /Bdkrb2 tm mice, referred to below as obWT and B2KO, respectively, all with the C57BL/6J genetic background, were obtained from the Center for the Development of Experimental Animal Models (CEDEME), Federal University of São Paulo (UNIFESP). The infertility of obWT male mice was reverted using the white adipose tissue transplantation technique. 22 Transplanted ob/ob males were mated with B2KO females to generate Lep ob .Bdkrb2 tm /Lep ob .Bdkrb2 tm , referred below as obB2KO. Mice were fed ad libitum with commercial rodent chow diet (Nuvi Lab, Nuvital Paraná, Brazil) and neutral pH water, and were maintained under a 12-h light/12-h dark cycle under constant room temperature (22 ± 1 1C) and humidity (60 ± 3%) conditions. The experiments were carried out with females. All procedures complied with the standards for the care and use of animals as stated in the guide for the care and use of laboratory animals (UNIFESP).
Glycemic Analysis
All glycemic tests were performed on 3-and 6-month-old mice. The glucose tolerance test and insulin tolerance test were performed in animals fasted for 12 h. To avoid stress there was an interval of 7 days between tests. Glycemia was measured from blood drops from tails using a glucometer (Accu-Chek Advantage). For the glucose tolerance test, 1 g glucose and for the insulin tolerance test 1 IU of insulin were i.p. injected per kg of body weight.
Serum Insulin Measurements
To measure serum insulin levels, blood samples were collected at 10 am from 3-and 6-month-old mice, after 12 h of fasting. The plasma was obtained by centrifugation at 2000 g and frozen at À 201C until use. The analyses were done with a rat/mouse Insulin ELISA Kit (Millipore).
Morphometric Analysis
To determine the growth curve and the obesity development, body weight was measured weekly until the mice reached the age of 26 weeks. Thirty-week-old mice were killed and their body weights as well as their organ weight were measured. Liver pieces were saved in buffered formalin or frozen in liquid nitrogen for further analysis. For histopathological analysis, liver sections were stained with hematoxylin and eosin.
Body Composition
Total body fat was estimated in 25-week-old mice by dualenergy X-ray absorptiometry using a Hologic QDR 4500 scanner (Hologic, Waltham, MA, USA) as described previously. 23 Quantitative RT-PCR Expression levels of different liver mRNAs were determined by quantitative real-time PCR. Briefly, tissue explants from 12 h fasted mice were removed, snap frozen in liquid nitrogen and stored at À 80 1C until use. Samples were homogenized and total RNA was isolated using a NucleoSpin RNA II purification kit (Macherey-Nagel) and then stored at À 80 1C until use. The RNA integrity was assessed by electrophoresis on agarose gels. cDNA was synthesized from 1 mg of total RNA with Moloney murine leukemia virus reverse transcriptase (Promega) using random hexamer nucleotides. Standard curves for these molecules were made to determine the amplification efficiencies of target and reference genes. Quantitative PCR was performed on an ABI Prism 7900 sequence detection system using 100 nM of primers and 5-20 ng of cDNA. Target mRNA expression was normalized to b-actin and expressed as a relative value using the comparative threshold cycle (Ct) method (2 À DDCt ) according to the manufacturer's instructions. Expression levels from genes of interest were normalized to obWT control mice.
Nuclear Protein Extraction
For nuclear extraction, 200 mg of fresh liver were homogenized with 0.8 ml hypotonic buffer (final concentrations: 10 mM HEPES-KOH, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.5% NP-40, 1 mM PMSF and one tablet of the Complete Inhibitor Cocktail (Roche) for each 25 ml of buffer). The homogenates were kept on ice for 20 min. After mixing, the samples were centrifuged at 2000 g, at 4 o C during 3 min. The cytoplasmic fractions were saved and the pellets resuspended in 180 ml hypertonic buffer (final concentrations: 20 mM HEPES-KOH, pH 7.9, 400 mM NaCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.2 mM EDTA, 15% glycerol, 1 mM PMSF and one tablet of the Complete Inhibitor Cocktail (Roche) for each 25 ml of buffer). After 30 min incubation on ice, the samples were centrifuged at 10 000 g, at 4 1C for 10 min. The supernatant containing the nuclear proteins were kept at À 801C for analyses of protein concentration and western blotting.
Western Blotting
Following the extraction procedure outlined above, the cytoplasmic and nuclear fractions were analyzed by western blotting. After separation by SDS-PAGE, proteins were transferred onto nitrocellulose membranes, which were blocked with 5% milk for 1 h at room temperature. Membranes were incubated overnight with primary antibodies (FKHR-sc-11350, Santa Cruz), washed with tris-buffered saline containing 0.1% Tween 20 and incubated with peroxidase-conjugated secondary antibodies for 1 h at room temperature. Membranes were washed, incubated with LumiGlochem iluminescence reagent and exposed on film.
Pyruvate Challenge Twenty-four-hour food-deprived mice were i.p. injected with sodium pyruvate (0.5 g/kg) for the pyruvate challenge test. Blood samples were taken from the tail vein immediately before and at various time points (30-240 min) after the pyruvate load.
Intraportal BK Injection
Lean wild-type C57BL/6J mice at the age of 3 months were anesthetized with fluoretane. The body temperature was kept constant by laying the mice onto a 37-1C-heating plate. The abdominal cavity was opened and four bolus of 10 À 3 M BK or saline was injected into the portal vein each 5 min totaling 100 ml of solution. After 30 min, fragments of the liver were collected and quickly frozen in liquid nitrogen until use for RNA extraction.
Cell Culture
Rat hepatoma cells (FAO) were cultured in RPMI 1640 supplemented with 10% FBS. Insulin, cAMP (N6,2 0 -O-dibutyryladenosine 3 0 ,5 0 -cyclic monophosphate sodium salt), BK and HOE140 were purchased from Sigma (St Louis, MO, USA). Groups were divided into 6 h fasting (without FBS) and a fed state group, and tested with BK (10 À 6 M) or HOE140 (10 À 6 M) þ BK (10 À 6 M) under three conditions: control, with insulin (1 unit/l) or with cAMP (10 mM). The cells were incubated during 3 h and the tRNA was extract for quantitative RT-PCR analysis using the Invisorb Spin Universal RNA Mini Kit (Invitek, Berlin, Germany).
Statistical Analysis
All values are expressed as mean ± s.e.m. Statistical analyses were carried out using the two-tailed Student's unpaired ttest to compare two independent groups or ANOVA followed by Bonferroni's test to compare more than two groups. Significance was rejected at PZ0.05.
RESULTS

BKB2R Deficiency Potentiates Hyperglycemia and Reduces Glucose Tolerance in obWT
The BKB2R has been shown to promote glucose uptake and GLUT4 translocation in muscle and adipose tissue through a insulin-dependent mechanism. 10, 11 In the absence of BKB2R, mice showed normal insulin sensitivity but reduced glucose tolerance (Figures 1a-f ). Additionally, 6-month-old obB2KO mice displayed a higher fasting hyperglycemia when compared with obWT (162.3±28.2 mg/dl vs 85.25±13.3 mg/dl, Figure 1g ). Interestingly, this difference was observed only in older mice. In fact, it has been shown that glucose metabolism is improved in ob/ob mice at the age of 20 weeks, [24] [25] [26] but this adaptation seems to be blunted in obB2KO mice. In our experiments, we observed that 6-month-old obWT mice showed lower glycemia than 3-month-old obWT mice (Figure 1g ). This correlates with a decrease in serum insulin levels in these animals (Figure 1h ), indicating that increased insulin secretion is not the reason for the improvement in basal glycemia.
BKB2R Deficiency Does not Affect Obesity or Fat
Accumulation in the ob/ob Model. Deficiency of leptin in ob/ob mice causes severe obesity. ObB2KO mice had similar body masses (60.55 ± 3.94 vs 66.70±7.38; obWT vs obB2KO, respectively), similar growth curves and similar body compositions (fat mass ¼ 68.80±2.97% vs 70.61±3.85%; lean mass 17.93±2.23% vs 20.61±3.66%, obWT vs obB2KO, respectively) than their controls (Figure 2a-d) . Body mass of the obB2KO mice was higher during some weeks (18-25 weeks of age) but no significant difference was found after 26 weeks (Figure 2a) . It is known that body fat distribution has a role in metabolism and insulin sensitivity. 27, 28 Fat distribution in obB2KO mice was similar to their controls when analyzed by dissection (Figure 2d) . Moreover, the mass of spleen, pancreas, kidney, skeletal muscle (gastrocnemius), heart and liver was not different between the groups (Figures 2e and 4c) .
The Gluconeogenesis Pathway is Upregulated in obB2KO mice In T2DM patients, increased gluconeogenesis was identified as the main cause of fasting hyperglycemia. 29 We thus examined the main organ of gluconeogenesis, the liver, and found that the expression of BKB2R mRNA was significantly increased with age in obWT mice (2.44 ± 0.48 fold, n ¼ 6, Figure 3a) , coinciding with the improvement in glucose metabolism. To test the gluconeogenesis pathway we used the pyruvate challenge test to compare the capacity of obWT and obB2KO mice to produce glucose from this substrate. The test was carried out after 24 h of fasting and showed a more prominent increase of glucose production in obB2KO mice (Figure 3b) , mainly 180 and 240 min after the injection. This increase in glucose production indicates increased gluconeogenesis in obB2KO mice, suggesting that BKB2R deficiency can influence this pathway in obWT.
Expression of Gluconeogenesis Regulatory Enzymes is Increased in obB2KO Mice
To assess the mechanism through which BKB2R deficiency could modulate glucose production, we analyzed the Figure 1 Reduction of basal glycemia and insulinemia in 6-month-old obese mice (obWT) mice. Glucose tolerance test (a-d) and insulin tolerance test (e, f) in 3-and 6-month-old mice, n ¼ 6; (g) fasting glycemia comparing 3-and 6-month-old mice, n ¼ 6; (h) plasma insulin levels, n ¼ 6. All tests were carried out with the animals after 12 h of fasting. Values are presented as mean±s.e.m., n45, *Po0.05 and **Po0.01. expression level of mRNAs coding for enzymes and factors involved in hepatic gluconeogenesis and found increased expression of G6Pase (eight-fold), PEPCK (three-fold), FoxO1 (four-fold) and peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC-1a, seven-fold) in liver of obB2KO when compared with obWT (Figure 4a ). G6Pase and PEPCK are important regulatory enzymes for activation of the gluconeogenesis pathway and both enzymes are transcriptionally controlled by FoxO1. 21 The 25-hydroxycholesterol 7-alpha-hydroxylase (CYP7b1) expression is dramatically decreased. Additionally, we found a decrease in the expression of glucokinase (GCK) mRNA in obB2KO. This enzyme is known to regulate the catabolism of glucose in hepatocytes by phosphorylation of glucose to glucose-6-phosphate. 30 Other genes related to lipid metabolism in the liver such as hepatocyte nuclear factor 4 alpha, 3-hydroxy-3-methyl-glutaryl-CoA reductase, sterol regulatory elementbinding transcription factor 1, carnitine palmitoyltransferase-1 and glycerol-3-phosphate acyltransferase were not different in obB2KO mice in comparison with obWT mice (Figure 4a) . Consistent with the role of these enzymes in lipid metabolism, liver histology showed no improvement of hepatic steatosis in obB2KO when compared with obWT mice (Figure 4b ). Liver mass was also similar between obB2KO and obWT (41.43±7.83 mg/g vs 40.83±6.83 mg/g body weight, respectively; Figure 4c ).
Expression and Cellular Distribution of FoxO1 Protein is Affected in obB2KO Mice
The nuclear exclusion of FoxO1 is an important mechanism to regulate glucose metabolism in the liver. Insulin can inhibit gluconeogenesis by Akt-mediated phosphorylation and consequent nuclear exclusion of FoxO1. 21 As a surrogate for the amount of functional FoxO1 in the hepatic cells of obWT and obB2KO mice, we performed western blot analysis of nuclear extracts of random fed and 24 h fasted mice. These analyses showed higher amounts of nuclear FoxO1 in the liver of fed, but not fasted obB2KO mice when compared with control mice ( Figure 5 ).
BK Injection into the Portal Vein Acutely Decreases the Expression of FoxO1 and PEPCK in Liver
To determine if BK could influence the expression of the gluconeogenesis regulatory enzymes in vivo, wild-type mice were anesthetized with isofluran and a bolus of BK was injected into their portal vein. Mice were killed and liver explants were collected 30 min after the first bolus. Data showed a significant decrease of the mRNA expression of FoxO1 and PEPCK (37.3 ± 14.3% and 49.1 ± 19.2%, respectively) when compared with controls ( Figure 6 ). These results therefore confirm that BK has an active role in the regulation of gluconeogenesis.
BK Effect on the mRNA Expression of Gluconeogenesis Factors in Hepatocytes Culture
To analyze whether the effect of BK in liver is due to the direct action of BK on hepatocytes or if it is dependent on other systems related with insulin sensitivity, we cultured rat hepatoma cells (FAO) in different conditions, adding BK alone or with the BKB2R antagonist HOE140. After 3 h, the tRNA was extracted and quantitative RT-PCR analyses were carried out. The cells reacted as expected to insulin or cAMP, respectively, inhibiting or activating the expression of both G6Pase and, PEPCK, when compared with the control cells. FBS starved cells presented increased expression of these factors keeping the same expression profiles in respect to insulin or cAMP addition. BK (10 À 6 M) could slightly decrease the mRNA expression of PEPCK and FoxO1, but not G6Pase in isolated FAO cells, and these effects were observed only after FBS starvation and stimulation with cAMP ( Figure 7) . Figure 4 The expression of forkhead box protein O1 (FoxO1), phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) is increased in the liver of obese mice lacking the bradykinin B2 receptor (obB2KO) mice. (a) Relative mRNA expression of enzymes involved in glucose and lipid metabolism in the liver: FoxO1, glucokinase (GCK), G6Pase, PEPCK, 25-hydroxycholesterol 7-alpha-hydroxylase (CYP7b1), hepatocyte nuclear factor 4 alpha (HNF4a), 3-hydroxy-3-methylglutaryl-CoA reductase (Hmgcr), peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC-1a); cyclic AMP-responsive element-binding protein 1 (CREB), sterol regulatory element-binding protein 1 (SREBPf1); carnitine palmitoyltransferase-1 (CPT1); acyl-CoA oxidase (ACO); glycerol-3-phosphate acyltransferase (GPAT); (b) representative microphotography of liver sections, stained with hematoxylin and eosin, of the obese mice (obWT) and obB2KO mice, showing a similar pattern of steatosis; (c) liver mass of 30-week-old mice; *Po0.05, **Po0.01, ***Po0.001, n ¼ 5. 
DISCUSSION
In order to study the participation of BK in the pathophysiology of obesity and T2DM, we generated a genetically modified mouse deficient in leptin and the BKB2R. These animals are as obese as their controls, which are deficient only in leptin. On the other hand, obB2KO mice show higher hyperglycemia and increased production of glucose during a pyruvate challenge. Interestingly, these differences appear only when the animals are 6 months old.
As the most important organ for gluconeogenesis is the liver, 31 we assessed the expression of BKB2R in the liver of obWT animals of two different ages. As previously described by several studies, the glycemia in obWT mice reduces when animals are 6-month-old compared with younger animals. [24] [25] [26] Our results confirm this observation and demonstrate that it coincides with an increase in BKB2R mRNA expression in the liver of obWT mice with age, suggesting that hepatic BKB2R might be involved in this process.
Although obB2KO mice do not show morphological changes in liver, the mRNA expression of the most important factors for activation of the gluconeogenesis was increased in the liver of these animals compared with controls. FoxO1, an important transcriptional factor to regulate gluconeogenesis in liver, 21 was increased at the mRNA level in the liver of obB2KO mice. This result is consistent with the increase of G6Pase and PEPCK mRNA expression observed in 6-monthold obB2KO mice. The transcription factors and coactivators involved in the control of gluconeogenesis have been studied by several authors and confirmed by chromatin immunoprecipitation assay. [32] [33] [34] [35] [36] FoxO1 is also known to inhibit the mRNA expression of CYP7A1. 37 Consistently, CYP7b1 expression is dramatically decreased in the liver of obB2KO mice. These results together with increased glucose production and higher hyperglycemia in obB2KO mice point to a chronic upregulation of the gluconeogenesis pathway in obB2KO mice.
One way of regulating the activity of FoxO1 is by the phosphorylation and subsequent nuclear exclusion of this factor in the cell. 38 The protein kinase B (AKT) is the main kinase responsible for nuclear exclusion of FoxO1. 39 Under conditions of abundant glucose, ie, during fed state, insulin is released and promotes activation of AKT in the liver with subsequent FoxO1 phosphorylation and nuclear exclusion. 40, 41 It then results in inhibition of expression of enzymes responsible for gluconeogenesis. 42 Under random fed regimen, obB2KO mice exhibit an atypical increase in nuclear FoxO1 levels. Interestingly, these levels are similar to the levels observed in fasted mice, which suggest that: (1) obB2KO are not responsive to insulin or other signals that inhibit gluconeogenesis in response to feeding; and (2) independently on the feeding status, nuclear FoxO1 is at its maximum levels in obB2KO mice. Thus, the increase in fasting gluconeogenesis should be related to the higher expression of PGC-1a in obB2KO, as it was reported that this co-activator is responsible for activation/stabilization of the transcriptional complex necessary for the transcriptional activity of FoxO1. 43 Furthermore, PGC-1a has also been associated with metabolic changes in the liver, especially with the activation of gluconeogenesis. 43 All these results are in consonance with Hartl et al, 44 who proposed that the favorable effects of systemic administration of kinins in humans could be mediated by prostaglandins. On the other hand, diet induced liver-insulin-resistance in rats was followed by decreased plasma BK level in a metabolomic analysis 45 suggesting that the insulin pathway could be involved in metabolic effect of BK in vivo. Although it is unclear whether the mechanism is insulin dependent or not, the present work shows that the KKS is involved in this process.
We also tested the effect of BK in cultured hepatoma cells. In this isolated system, BK had only a slight effect to inhibit PEPCK and FoxO1 expression, but none regarding G6Pase. This effect was blocked by previous incubation with the BKB2R antagonist HOE140. These results are similar to those observed after BK injection in the portal vein in vivo (Figure 6 ), suggesting that the chronic effects of BK in obB2KO mice are also dependent on other systems as suggest by Li et al, 45 who showed a cross talking between the KKS and the insulin pathway, 45 and other several studies that show the influence of BK in insulin secretion of the pancreatic cells. [46] [47] [48] [49] It is important to highlight that this finding was only observed in cells that were FBS starved during 6 h and were also stimulated with cAMP, the second messenger of the glucagon receptor pathway.
The model of obesity used in the present work was important to demonstrate the effect of BK in hepatic gluconeogenesis. Duka et al 5 showed that the lean B2KO mice have significantly higher steady-state insulin levels, significantly lower glucose uptake rates and insulin sensitivity indexes, but did not analyze hepatic gluconeogenesis. We challenged these lean mice with the pyruvate tolerance test (Supplementary Figure S1 ) and we also carried out hepatic mRNA expression analysis of some gluconeogenesis factors (FoxO1, G6Pase, PEPCK and PGC-1; Supplementary Figure S2) . The analyses did not show differences in gluconeogenesis activity or in expression of these factors in the lean B2KO mice when compared with the lean WT controls, as presented in the supplementary data.
In summary, these results show that the BKB2R participates in the regulation of hepatic glucose production of obWT, but not in lean mice. This scenario takes place with an increase in the expression and a decrease in the nuclear exclusion of FoxO1 and consequent increase in the expression of PEPCK and G6Pase mRNAs. Increased activity of FoxO1 in obB2KO during fasting is also promoted by increased PGC-1a. It points to a protective effect of BK and its analogs in obese, T2DM individuals. 
